Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy
Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma
· 10/21/2026, 9:50:58 AM· 2 min read
Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma
Read original story →Related stories
breaking
Non-monsoon timetable comes into effect on Konkan route
breaking
Vizianagaram Mayor poll moved to October 29 over Sirimanotsavam; counting stays on October 30
breaking
Sabarimala pilgrimage: KSRTC to deploy over 1,000 buses
breaking